Sansure Biotech Inc. (SHA:688289)
China flag China · Delayed Price · Currency is CNY
18.51
+0.10 (0.54%)
Mar 10, 2026, 11:29 AM CST

Sansure Biotech Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Cash & Equivalents
-4,5904,2333,2132,636
Upgrade
Trading Asset Securities
-139.67548.282,4512,046
Upgrade
Cash & Short-Term Investments
4,0054,7304,7825,6644,683
Upgrade
Cash Growth
-15.32%-1.09%-15.57%20.95%11.70%
Upgrade
Accounts Receivable
-560.69692.261,298807.66
Upgrade
Other Receivables
-27.5823.4982.4114.3
Upgrade
Receivables
-588.27715.751,381821.95
Upgrade
Inventory
-392.75376.63355.31369.5
Upgrade
Other Current Assets
-78.775.45125.8392.09
Upgrade
Total Current Assets
-5,7905,9507,5255,966
Upgrade
Property, Plant & Equipment
-1,1131,043785.27481.03
Upgrade
Long-Term Investments
-1,096974.33657.43513.23
Upgrade
Goodwill
-7.667.66--
Upgrade
Other Intangible Assets
-334.67283.2879.1245.55
Upgrade
Long-Term Deferred Tax Assets
-69.2873.8269.6225
Upgrade
Long-Term Deferred Charges
-147.2797.0546.716.26
Upgrade
Other Long-Term Assets
-47.0425.1610.1943.08
Upgrade
Total Assets
-8,6048,4549,1747,090
Upgrade
Accounts Payable
-225.78271.14586.26188.82
Upgrade
Accrued Expenses
-290.03363.33622.39231.82
Upgrade
Short-Term Debt
-99--
Upgrade
Current Portion of Leases
-5.2811.114.268.49
Upgrade
Current Income Taxes Payable
-0.2117.66145.2580.16
Upgrade
Current Unearned Revenue
-64.5532.8153.1178.64
Upgrade
Other Current Liabilities
-159.94214.12150.4576.01
Upgrade
Total Current Liabilities
-754.8919.151,572663.93
Upgrade
Long-Term Debt
-396.65---
Upgrade
Long-Term Leases
-11.9218.2113.66.41
Upgrade
Long-Term Unearned Revenue
-39.8832.4930.5325.68
Upgrade
Long-Term Deferred Tax Liabilities
-54.7559.4519.0413.01
Upgrade
Other Long-Term Liabilities
---26.09-
Upgrade
Total Liabilities
-1,2581,0291,661709.03
Upgrade
Common Stock
-582.39588.46588.46400
Upgrade
Additional Paid-In Capital
-1,7021,9081,9142,065
Upgrade
Retained Earnings
-5,1945,1775,3714,082
Upgrade
Treasury Stock
--274.29-515.33-392.6-200.01
Upgrade
Comprehensive Income & Other
-39.0143.2619.3621.71
Upgrade
Total Common Equity
7,1317,2437,2017,5016,369
Upgrade
Minority Interest
-102.56223.6412.1612.43
Upgrade
Shareholders' Equity
7,2207,3467,4257,5136,381
Upgrade
Total Liabilities & Equity
-8,6048,4549,1747,090
Upgrade
Total Debt
1,103422.8538.3127.8614.9
Upgrade
Net Cash (Debt)
2,9024,3074,7435,6364,668
Upgrade
Net Cash Growth
-32.61%-9.20%-15.83%20.74%12.83%
Upgrade
Net Cash Per Share
4.987.358.099.637.93
Upgrade
Filing Date Shares Outstanding
591.88573.72573.52578.69592
Upgrade
Total Common Shares Outstanding
574.18573.72572.21578.69592
Upgrade
Working Capital
-5,0355,0305,9545,302
Upgrade
Book Value Per Share
12.4212.6212.5912.9610.76
Upgrade
Tangible Book Value
5,8456,9016,9107,4216,323
Upgrade
Tangible Book Value Per Share
10.1812.0312.0812.8210.68
Upgrade
Buildings
-834.41826.53344.51231.04
Upgrade
Machinery
-607.96436.62322.65270.13
Upgrade
Construction In Progress
-3.584.59267.76110.45
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.